ERIS1,358.00

Eris Lifesciences Ltd.

· Pharma & Health
₹ CrorePeersMANKINDAJANTPHARMTORNTPHARMEMCUREGRANULESCONCORDBIOINDGNCAPLIPOINTMcap ₹18,808 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment504.6662.1708.4708.4
+ Capital Work-in-Progress19.166.7171.5171.5
+ Goodwill861.2912.0912.0912.0
+ Other Intangibles2,961.73,732.43,567.23,567.2
+ Intangibles under Development0.60.30.00.0
+ Investments (Equity Method)0.051.551.651.6
+ Non-current Investments15.510.510.010.0
+ Long-term Loans1.01.11.11.1
+ Other Non-current Financial Assets9.310.89.89.8
Non-current Financial Assets25.922.420.920.9
+ Deferred Tax Assets306.9289.0242.9242.9
+ Other Non-current Assets66.734.2151.2151.2
Total Non-current Assets4,746.85,770.65,825.75,825.7
Current Assets
+ Inventories189.0334.8436.8436.8
+ Current Investments0.05.00.00.0
+ Trade Receivables422.0458.6680.3680.3
+ Cash & Cash Equivalents94.2199.754.754.7
+ Other Bank Balances1,306.423.112.612.6
+ Short-term Loans5.65.852.852.8
+ Other Current Financial Assets2.23.29.19.1
Current Financial Assets1,830.4695.4809.5809.5
+ Other Current Assets282.6192.7293.6293.6
Total Current Assets2,302.11,262.51,539.91,539.9
Total Assets7,048.87,033.27,365.57,365.5
Equity
+ Equity Share Capital13.613.613.913.9
+ Other Equity / Reserves2,572.52,840.73,888.83,888.8
Equity — Owners of Parent2,586.12,854.43,902.73,902.7
+ Minority Interest635.9417.4-7.0-7.0
Total Equity3,222.03,271.83,895.73,895.7
Liabilities
+ Borrowings — Non-current654.51,781.7955.8955.8
+ Other Non-current Financial Liab43.36.441.341.3
Non-current Financial Liabilities697.81,788.1997.1997.1
+ Provisions — Non-current52.769.086.886.8
+ Deferred Tax Liabilities542.8518.5305.1305.1
+ Other Non-current Liabilities1.44.53.83.8
Non-current Liabilities1,294.72,380.01,392.81,392.8
+ Borrowings — Current2,080.8696.21,353.91,353.9
+ Trade Payables268.3332.4329.7329.7
+ Other Current Financial Liab32.4165.1206.5206.5
Current Financial Liabilities2,381.51,193.71,890.01,890.0
+ Provisions — Current62.078.137.737.7
+ Current Tax Liabilities39.643.677.877.8
+ Other Current Liabilities49.066.071.671.6
Current Liabilities2,532.11,381.42,077.12,077.1
Total Liabilities3,826.83,761.43,469.93,469.9
Total Equity & Liabilities7,048.87,033.27,365.57,365.5
Assets — additional as-filed lines
+ Current Tax Assets0.039.50.00.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current16.08.88.8
+ Dues to Other Creditors — Current316.4320.9320.9
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.